Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D2.
D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000009:adverse effects*; D002118:Calcium / Q000097:blood; D002547:Cerebral Palsy / Q000150:complications / Q000188:drug therapy; D002648:Child; D002674:Child, Institutionalized; D002675:Child, Preschool; D004097:Dihydrotachysterol / Q000008:administration & dosage / Q000627:therapeutic use; D004872:Ergocalciferols / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage / Q000627:therapeutic use*; D007015:Hypophosphatemia, Familial / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008607:Intellectual Disability / Q000150:complications / Q000188:drug therapy; D008297:Male; D010757:Phosphorous Acids / Q000097:blood; D011859:Radiography; D013997:Time Factors; D014807:Vitamin D / Q000378:metabolism; D014953:Wrist / Q000000981:diagnostic imaging
D000927:Anticonvulsants; D004872:Ergocalciferols; D006887:Hydroxycholecalciferols; D010757:Phosphorous Acids; D014807:Vitamin D; D000469:Alkaline Phosphatase; D004097:Dihydrotachysterol; D002118:Calcium